Salarius Pharmaceuticals Inc (SLRX) — Financial Flexibility Index
Salarius Pharmaceuticals Inc (SLRX) has a Financial Flexibility Index of -0.89x as of September 2025. Free cash flow of $-1.65 Million (operating CF $-1.65 Million minus capex $0.00) represents -1% of total liabilities ($1.85 Million). Check Salarius Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Salarius Pharmaceuticals Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Salarius Pharmaceuticals Inc across 10 annual periods. See Salarius Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Salarius Pharmaceuticals Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Salarius Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is Salarius Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.99x | $-4.53 Million | $-4.53 Million | $1.51 Million | ▲ +69.7% |
| 2023 | -9.89x | $-12.85 Million | $-12.85 Million | $1.30 Million | ▼ -162.1% |
| 2022 | -3.77x | $-16.10 Million | $-17.60 Million | $4.27 Million | ▲ +21.9% |
| 2021 | -4.83x | $-10.20 Million | $-10.20 Million | $2.11 Million | ▼ -30.0% |
| 2020 | -3.72x | $-10.31 Million | $-10.31 Million | $2.77 Million | ▼ -6.4% |
| 2019 | -3.49x | $-11.58 Million | $-11.58 Million | $3.31 Million | ▲ +83.6% |
| 2018 | -21.32x | $-23.60 Million | $-23.60 Million | $1.11 Million | ▼ -354.5% |
| 2017 | -4.69x | $-27.61 Million | $-27.72 Million | $5.89 Million | ▲ +42.0% |
| 2016 | -8.08x | $-31.49 Million | $-32.05 Million | $3.90 Million | ▼ -13.5% |
| 2015 | -7.12x | $-20.48 Million | $-20.75 Million | $2.88 Million | — |